ANI Pharmaceuticals, Inc. (ANIP) Stock

ANI Pharmaceuticals, Inc. (ANIP) is a Healthcare stock trading at $79.40 (as of 2026-06-18), with a market capitalization of $1.62B and a trailing P/E of 20.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

ANI Pharmaceuticals, Inc. develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. Its portfolio includes controlled substances, oncology products, hormones and steroids, injectables and other formulations, and it also provides contract development and manufacturing for pharmaceutical products for other companies.

Valuation — source: SEC EDGAR (first-party)
Price$79.40
Market Cap$1.62B
P/E Ratio20.9
EV / EBITDA8.2
Price / Book3.13
Price / Sales1.91
Dividend Yield0.0%
DCF Value (model)$191.23
DCF Upside vs Price140.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$883.37M
Net Margin8.9%
Return on Equity16.4%
Debt / Equity0.54
Current Ratio3.12
Revenue Growth (YoY)20.5%
EPS Growth (YoY)87.1%
FCF Growth (YoY)60.8%
Financial Health — source: SEC EDGAR
Altman Z-Score2.43 (grey)
Valuation vs Sector & Industry
Stock P/E20.9
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-0.3%
vs Industry21.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($211.28M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEONikhil Lalwani
Employees897
CountryUS
IPO Date2000-05-05

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Sionna Therapeutics, Inc. (SION)
  • Syndax Pharmaceuticals, Inc. (SNDX)
  • Harrow Health, Inc. (HROW)
  • Pharvaris N.V. (PHVS)
  • Nurix Therapeutics, Inc. (NRIX)
  • Dianthus Therapeutics, Inc. (DNTH)
  • MannKind Corporation (MNKD)
  • Kodiak Sciences Inc. (KOD)
ANIP earnings history · ANIP institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.